Key points are not available for this paper at this time.
Design
Expert panel statement
Non-fasting triglycerides and remnant cholesterol may refine ASCVD risk stratification; leaves open whether targeting postprandial lipaemia improves outcomes.
Keywords: Postprandial lipaemia, non-fasting triglycerides, chylomicron remnants, very low-density lipoprotein remnants, remnant cholesterol, fat tolerance test, atherosclerotic cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Kolovou et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: